Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
12.66
Price to sales ratio
2.39
Dividends per share
0.63
Dividend yield %
7.58

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
82
GILD
Gilead Sciences, Inc. - Common Stock
151.00 USD-0.15%+4.69%+12.69%+31.58%187.23 B USD
101
PFE
Pfizer, Inc. Common Stock
28.45 USD-1.28%+2.15%+9.34%+14.07%162.16 B USD
148
SNY
Sanofi - American Depositary Shares
44.24 USD-0.20%-0.78%+2.17%-5.06%107.89 B USD
150
GSK
GSK plc American Depositary Shares
49.90 USD-1.93%-1.19%-4.84%+13.80%107.67 B USD

Frequently asked questions about Bristol-Myers Squibb Co.

What is the Bristol-Myers Squibb Co. stock price today?

The current price of Bristol-Myers Squibb Co. (BMY) is 66.83. Over the past 24 hours, the stock has changed by -1.85%. Follow the BMY chart for real-time price dynamics.

What is the stock ticker of Bristol-Myers Squibb Co.?

Bristol-Myers Squibb Co. trades under the ticker BMY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bristol-Myers Squibb Co. stock going up?

BMY has changed by +0.95% over the last week, +2.96% over the last month, and +43.38% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Bristol-Myers Squibb Co.?

Bristol-Myers Squibb Co. currently has a market capitalization of 136.51 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Bristol-Myers Squibb Co. release financial reports?

Yes. You can track Bristol-Myers Squibb Co. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Bristol-Myers Squibb Co. earnings last quarter?

Last quarter, Bristol-Myers Squibb Co. reported earnings of 1.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Bristol-Myers Squibb Co. revenue for the last quarter?

Bristol-Myers Squibb Co. reported quarterly revenue of 12.97 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Bristol-Myers Squibb Co. net income for the last quarter?

Bristol-Myers Squibb Co. reported net income of 3.32 B for the last quarter. The previous quarter showed 2.68 B, which means net income changed by +23.91%.

Does Bristol-Myers Squibb Co. pay dividends?

Bristol-Myers Squibb Co. paid a dividend per share of 0.63. The current dividend yield is 7.58%. Dividend data can help income-focused investors evaluate the stock.

Is Bristol-Myers Squibb Co. a good dividend stock?

Bristol-Myers Squibb Co. currently has a dividend yield of 7.58%. Previously, the dividend yield was 7.19%, compared with 4.62% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.

How many employees does Bristol-Myers Squibb Co. have?

As of the latest available data, Bristol-Myers Squibb Co. has 32.5 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Bristol-Myers Squibb Co. EBITDA?

Bristol-Myers Squibb Co. EBITDA is 4.68 B, and its EBITDA margin is 36.07%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bristol-Myers Squibb Co. stock?

You can buy Bristol-Myers Squibb Co. (BMY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bristol-Myers Squibb Co. stock?

Investing in Bristol-Myers Squibb Co. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BMY chart and related analysis on metatrader.com as part of your research.

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.

News